Misdiagnosis and Chemotherapy Delaying Reduces the Chemosensitivity of Choriocarcinoma Patient: Analysis of 36 Cases
Background: Choriocarcinoma is a curable malignant neoplasm when chemotherapy is properly implemented. However, when chemotherapy resistance occurs, disease can be fatal. Misdiagnosis is common, which may lead to delaying of the first cycle of chemotherapy and increase the possibility of chemoresist...
Saved in:
Main Authors: | Lin-Jing Yuan (Author), Yu-Ying Chen (Author), Cai-Xia Zhu (Author), Yi-Zi Wang (Author), Guo-Fen Yang (Author) |
---|---|
Format: | Book |
Published: |
IMR Press,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retreatment of chemotherapy-resistant metastatic choriocarcinoma with immunotherapy
by: Adriana J. Wong, et al.
Published: (2022) -
Gestational choriocarcinoma complicated by infective endocarditis during chemotherapy
by: Tadaharu Nakasone, et al.
Published: (2017) -
Point-of-Care Ultrasound May Reduce Misdiagnosis of Pediatric Intussusception
by: Hsiang-Ju Hsiao, et al.
Published: (2021) -
Misdiagnosi
by: Paolo Colomba
Published: (2017) -
Editorial: Chemosensitizing effect of natural products against cancers: Applications in enhancing chemotherapy and immunotherapy
by: Nand K. Roy, et al.
Published: (2022)